Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1993-2-24
pubmed:abstractText
We analyzed epsilon-globin transcription in erythroid cells and in erythroid extracts to determine the requirements for enhancer-dependent expression of this gene. Mutations that abolished GATA-1 binding at a single position in the promoter prevented interaction with enhancers, whereas elimination of a second more distal promoter GATA-1 site had no effect. Deletion or mutation of the GATA-1 sites in either the human beta-globin locus control region DNase-hypersensitive site II enhancer or the chicken beta A/epsilon-globin enhancer did not diminish the ability of the enhancers to interact with the promoter. In contrast, mutation of the AP-1/NF-E2 sites in these enhancers resulted in elimination of enhancement. In vitro transcription of these constructs was promoter dependent and was not sensitive to abolition of GATA-1 binding in the promoter, consistent with the role of GATA-1 solely as a mediator of the enhancer effect. Thus, GATA-1 regulates the response of the epsilon-globin gene to enhancers through a specific site in the promoter and requires enhancer AP-1/NF-E2 binding to transduce the enhancer effect on transcription.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1373805, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1408744, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1549112, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1559609, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1569944, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1570310, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1577269, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1668190, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1731219, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1850324, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1924329, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1946439, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1987478, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-1990287, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2000371, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2014222, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2017165, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2026603, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2044960, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2116990, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2123346, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2180450, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2180585, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2216720, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2225071, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2235483, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2251502, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2275826, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2326182, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2357965, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2467208, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2594805, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2620825, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2704733, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2771941, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2776214, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-2911469, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-3166139, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-3413070, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-3456593, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-3474625, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-3690667, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-3859838, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-3879975, http://linkedlifedata.com/resource/pubmed/commentcorrection/8423810-6828386
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0270-7306
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
911-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Enhancer-dependent transcription of the epsilon-globin promoter requires promoter-bound GATA-1 and enhancer-bound AP-1/NF-E2.
pubmed:affiliation
Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
pubmed:publicationType
Journal Article